BP Unleashes $5 Billion Deepwater Giant in Gulf of Mexico

Market Movers Revealed: Unpacking Last Week's Large-Cap Triumphs!

Biogen's High-Dose Spinraza Hits Regulatory Snag: FDA Issues Refusal to File

Micron's AI Revolution: CEO Sanjay Mehrotra Declares AI the Undeniable Catalyst for Record-Breaking Growth

European Experts Back Two AstraZeneca Breakthroughs: New Hope for Rare Diseases

Pfizer's Bold Leap: Eyeing Metsara in Blockbuster Acquisition Bid

DRC Unveils Game-Changing Cobalt Export System: A New Era for the Global Market

Billionaire David Tepper: Why He Hates This Market But Won't Challenge the Fed

A Beacon of Hope: Regeneron's Pozelimab Shines in Ultra-Rare Genetic Disorder Study

The Billionaire's Gaze: How Palantir's Valuation Inspired Marc Benioff to Rethink Salesforce's Price Tag

A New Horizon in Bladder Cancer Treatment: J&J's Balversa Secures Full FDA Approval

Equity Mutual Fund Inflows Dip 21% in August, But SIPs Soar to New High

Oracle Defies Gravity: Why Its Stock Soared After a Q1 Earnings 'Miss'

Navigating the Cosmic Currents: Planet Labs Soars, EchoStar Eyes Starlink, and AST SpaceMobile Faces Turbulence

UnitedHealthcare Expands Glaucoma Treatment Access by Covering Sight Sciences' OMNI System

PTC Therapeutics: A New Titan Rising to Challenge BioMarin's Reign in Rare Disease Treatment

Summit Therapeutics' Lung Cancer Hope Faces Fierce Competition and Scrutiny

Global Health Titans Act: FDA Tightens Grip on Safe Weight-Loss Meds as WHO Elevates Them to Essential Status

The Looming Uranium Crisis: Will Nuclear Power's Ambitions Be Derailed by 2030?

Salesforce's AI Aspirations: A Revolution or Just a Ripple?

A Major Setback for Amgen: Bemarituzumab's Gastric Cancer Ambitions Dim as Final Data Fails to Impress

Sanofi Stock Plunges as Zantac Lawsuit Risks Re-Emerge Following Key Judicial Ruling

Amazon Unveils 'Quick Suite': Igniting the Next Generation of AI Agents for a Smarter Future

Merck's Game-Changing Oral Pill Poised to Revolutionize Cholesterol Treatment

AstraZeneca's Baxdrostat: A Beacon of Hope in the Fight Against Uncontrolled High Blood Pressure

Microsoft Unveils $6 Billion Digital Transformation for US Government

Wegovy Triumphs: Novo Nordisk's Obesity Drug Significantly Cuts Heart Attack and Stroke Risk, Setting a New Benchmark in Cardiovascular Protection

A New Dawn in Oncology: Kite Pharma's $350 Million Acquisition of Interius Biotherapeutics Set to Revolutionize CAR T-Cell Therapy

Unlocking Value: Why Analysts See Further Divestitures on Medtronic's Horizon

Oscar Health's Tumultuous Ride: What's Driving the Stock's Plummet?

Nifty LargeMidcap 250: Navigating Market Dynamics on August 20, 2025

The Weighty Truth: Are Next-Gen Obesity Drugs Worth Their Premium Price Tag?

Wall Street Roars: Tech Titans, Crypto Currents, and Pharma Shakes Up Tuesday's Trading!

Viking Therapeutics' Oral Weight Loss Drug Stumbles: VK2735 Data Leaves Investors Underwhelmed

Medtronic Soars: Upgraded Outlook & Bold Board Moves Signal New Era Post-Elliott

The Trump 2.0 Market Shift: Palantir Soars While Tesla Stumbles 200 Days In

Starlink's Unsettling Stutter: Second Outage in Fortnight Raises Reliability Red Flags

Michael Burry's Big Bet: Why the 'Big Short' Investor Is Plunging $40 Million into Estée Lauder

Buffett's Bold Bet: Why Berkshire Hathaway Is Doubling Down on UnitedHealth